Q Yan, Y Ding, Y Liu, T Sun, LG Fritsche, T Clemons, R Ratnapriya, ... Human molecular genetics 27 (5), 929-940, 2018. 98: ... R Zhang, Y Jiang, S Kim, Q Yan, Z Ren, YY Han, N Boutaoui, ... The Journal of allergy and clinical immunology 146 (3), 671, 2020. 37: 2020: Activation mechanisms of αVβ3 integrin by binding to fibronectin: a ...

Search; Search Search . Plant Sciences & Plant Pathology; Directory; Faculty

Kim AB, Xiao Q, Yan P, Pan Q, Pandey G, Grathwohl S et al. Chimeric antigen receptor macrophages target and resorb amyloid plaques. JCI Insight . 2024;9(6):e175015. doi: 10.1172/jci.insight.175015 Powered by Pure , Scopus & Elsevier Fingerprint Engine™

Qi YAN, Principal Research Scientist | Cited by 7,281 | of Massachusetts Institute of Technology, MA (MIT) | Read 50 publications | Contact Qi YAN

Qi Yan leads the development of cutting-edge detector reconstruction algorithms for the AMS collaboration. His pioneering developments, spanning various subfields, have significantly enhanced detector performance.

We devote the most attention to 1D nanostructures that have been synthesized in relatively copious quantities using chemical methods. We begin this article with an overview of synthetic strategies that have been exploited to achieve 1D growth.

Apr 28, 2023 · Yan P., Kim K.W., Xiao Q., Ma X., Czerniewski L.R., Liu H., Rawnsley D.R., Yan Y., Randolph G.J., Epelman S., Lee J.M., and Diwan A.. 2022. Peripheral monocyte-derived cells counter amyloid plaque pathogenesis in a mouse model of Alzheimer’s disease.

Douglas I. Walker Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University Verified email at emory.edu

William Y. Kim, M.D. Professor of Medicine, Genetics, and Pharmacology UNC Verified email at med.unc.edu Wenyi Wei Professor, Dept. of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School Verified email at bidmc.harvard.edu

Mar 22, 2024 · Here, we describe what we believe to be a novel approach to target and degrade amyloid plaques by genetically engineering macrophages to express an Aβ-targeting chimeric antigen receptor (CAR-Ms).